Thrombotic Risk Determined by STAB 2 Variants in a Population-Based Cohort Study

Authors :: Eric Manderstedt
Christer Halldén
Christina Lind-Halldén
Johan Elf
Peter J. Svensson
Gunnar Engström
Olle Melander
Aris Baras
Luca A Lotta
Bengt Zöller
Goncalo Abecasis
Michael Cantor
Giovanni Coppola
John D. Overton
Jeffrey G. Reid
Alan Shuldiner
Katia Karalis
Katherine Siminovitch
Christina Beechert
Caitlin Forsythe
Erin D. Fuller
Zhenhua Gu
Michael Lattari
Alexander Lopez
Thomas D. Schleicher
Maria Sotiropoulos Padilla
Louis Widom
Sarah E. Wolf
Manasi Pradhan
Kia Manoochehri
Ricardo H. Ulloa
Xiaodong Bai
Suganthi Balasubramanian
Andrew Blumenfeld
Boris Boutkov
Gisu Eom
Lukas Habegger
Alicia Hawes
Shareef Khalid
Olga Krasheninina
Rouel Lanche
Adam J. Mansfield
Evan K. Maxwell
Mrunali Nafde
Sean O’Keeffe
Max Orelus
Razvan Panea
Tommy Polanco
Ayesha Rasool
William Salerno
Jeffrey C. Staples
Niek Verweij
Jonas Nielsen
Tanima De
Marcus B. Jones
Jason Mighty
Michelle G. LeBlanc
Lyndon J. Mitnaul
Source :: Circulation: Genomic and Precision Medicine. 14
Publication Year :: 2021
Publisher :: Ovid Technologies (Wolters Kluwer Health), 2021.

Subjects :: Thrombotic risk
medicine.medical_specialty
education.field_of_study
business.industry
Population
General Medicine
medicine.disease
Thrombosis
Population based cohort
Internal medicine
Medicine
business
education
Venous thromboembolism

Tools